Clinical Trials Browser

Phase 1 × Triple Negative Breast Neoplasms × enzalutamide × Clear all

NCT03207529 2024-10-10

Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms